DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication
Artículo científico (JournalArticle)
COVID-19 in patients with haematologic malignancies: Effect of RNAemia on clinical outcome in vaccinated patients
Patients with haematologic malignancies (HM) COVID-19 have more severe disease, with increased risk of mortality. Therefore, this study aimed to evaluate the effect of SARS-CoV-2 RNAemia and the specific humoral immune responses on the clinical outcomes of patients with HM and COVID-19., This study was supported by Plan Nacional de I+D+i 2013‐2016 and Instituto de Salud Carlos III, Subdirección General de Redes y Centros de Investigación Cooperativa, Ministerio de Ciencia, Innovación y Universidades, Spanish Network for Research in Infectious Diseases (
REIPI RD16/0016/0009
); co‐financed by European Development Regional Fund ‘A way to achieve Europe’, Operative Program Intelligence Growth 2014‐2020; and supported by the grant
PI21/01569
from the Instituto de Salud Carlos III and the grant
IM22/INF/13
from the CIBERINFEC, Instituto de Salud Carlos III, Spain. RA-M, LM, JMC, EC, JS-C and MA-G (
CB21/13/00006
) and ZRP-B, and PP-P (
CB21/13/00012
) were also supported by CIBERINFEC – Consorcio Centro de Investigación Biomédica en Red, Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación and Unión Europea – NextGenerationEU. JM-E was supported by a predoctoral health research training contracts from the Instituto de Salud Carlos III (
FI22/00025
). JS-C is a researcher belonging to the program ‘Nicolás Monardes’ (C-0059-2018), Servicio Andaluz de Salud, Junta de Andalucía, Spain., Peer reviewed
DOI: http://hdl.handle.net/10261/368562, https://api.elsevier.com/content/abstract/scopus_id/85199331535
HANDLE: http://hdl.handle.net/10261/368562, https://api.elsevier.com/content/abstract/scopus_id/85199331535